卡泊三醇软膏联合胸腺肽肠溶片治疗斑块状银屑病的临床疗效OA
Clinical Efficacy of Calcipotriol Ointment Combined with Thymosin Enteric-coated Tablets in the Treatment of Plaque-type Psoriasis
目的 探讨卡泊三醇软膏联合胸腺肽肠溶片治疗斑块状银屑病的临床疗效.方法 选取2023年1月至2025年3月辽宁省健康产业集团阜新矿总医院收治的108 例斑块状银屑病患者,采用随机数字表法分为对照组和观察组,每组54 例.对照组单用卡泊三醇软膏治疗,观察组在对照组基础上联合胸腺肽肠溶片治疗.比较两组患者银屑病面积与严重程度指数(PASI)评分、临床疗效,同时检测血清辅助性T细胞1(Th1)、辅助性T细胞17(Th17)细胞因子,统计复发与不良反应发生情况.结果 治疗后两组PASI评分均降低(P<0.05),且观察组低于对照组(P<0.05).观察组治疗有效率为92.59%,高于对照组的 74.07%(P<0.05).与对照组相比,观察组治疗后肿瘤坏死因子-α(TNF-α)、γ 干扰素(IFN-γ)、白细胞介素-17(IL-17)、白细胞介素-22(IL-22)水平更低(P<0.05).两组复发率差异无统计学意义(P>0.05),但观察组复发间隔时间明显延长(P<0.05).两组不良反应发生率差异无统计学意义(P>0.05).结论 卡泊三醇软膏联合胸腺肽肠溶片治疗斑块状银屑病临床疗效显著,可有效减轻症状,改善Th细胞免疫紊乱,延长复发间隔时间,且安全性较高.
Objective To explore the clinical efficacy of calcipotriol ointment combined with thymosin enteric-coated tablets in the treatment of plaque-type psoriasis.Methods A total of 108 patients with plaque psoriasis who were admitted to Fuxin General Hospital of Liaoning Health Industry Group from January 2023 to March 2025 were selected.They were randomly divided into the control group and the observation group,with 54 cases in each group.The control group was treated with calcipotriol ointment alone,while the observation group was treated with calcipotriol ointment externally combined with thymosin enteric-coated tablets.The psoriasis area and severity index(PASI)scores and clinical efficacy of the two groups were compared,and serum helper T cell 1(Th1)and helper T cell 17(Th17)cytokines were detected.The recurrence and adverse reactions were also statistically analyzed.Results After treatment,the PASI scores of both groups decreased(P<0.05),and the score of the observation group was lower than that of the control group(P<0.05).The effective rate of treatment in the observation group was 92.59%,which was higher than 74.07%in the control group(P<0.05).Compared with the control group,the levels of tumor necrosis factor-α(TNF-α),interferon-γ(IFN-γ),interleukin-17(IL-17),and interleukin-22(IL-22)in the observation group were lower after treatment(P<0.05).There was no statistically significant difference in the recurrence rate between the two groups(P>0.05),but the recurrence interval in the observation group was significantly longer(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of calcipotriol ointment and thymosin enteric-coated tablets has a remarkable clinical efficacy in treating plaque psoriasis.It can effectively alleviate symptoms,improve Th cell immune disorder,prolong the recurrence interval,and has a relatively high safety profile.
沈路路;聂丽
辽宁省健康产业集团阜新矿总医院皮肤性病科,辽宁 阜新 123000辽宁省健康产业集团阜新矿总医院皮肤性病科,辽宁 阜新 123000
医药卫生
银屑病卡泊三醇软膏胸腺肽肠溶片免疫调节
PsoriasisCalcipotriol ointmentThymosin enteric-coated tabletsImmune regulation
《中国药物经济学》 2026 (6)
49-52,60,5
评论